Zenas BioPharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZBIO and other ETFs, options, and stocks.

About ZBIO

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company. The firm is mainly engaged in the development and commercialization of transformative immunology-based therapies for patients. 

CEO
Leon Oliver Moulder
CEOLeon Oliver Moulder
Employees
130
Employees130
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2019
Founded2019
Employees
130
Employees130

ZBIO Key Statistics

Market cap
498.57M
Market cap498.57M
Price-Earnings ratio
-3.06
Price-Earnings ratio-3.06
Dividend yield
—
Dividend yield—
Average volume
154.34K
Average volume154.34K
High today
$12.45
High today$12.45
Low today
$11.53
Low today$11.53
Open price
$11.53
Open price$11.53
Volume
111.30K
Volume111.30K
52 Week high
$26.25
52 Week high$26.25
52 Week low
$5.83
52 Week low$5.83

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ZBIO. This list is generated using Robinhood data, and it’s not a recommendation.
D-Wave Quantum
SoundHound AI
Rigetti Computing
Intuitive Machines
Intel
AMD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.